New Delhi, April 24 (IANS) The Central government’s Indian Pharmacopoeia Commission has signed two memoranda of understandings (MoU) with two government institutes to strengthen quality assurance, ensure rational use of medicines, pharmacovigilance and collaborative research, an official statement said on Friday.One MoU with the Pharmaceuticals & Medical Devices Bureau of India aims to enhance the quality assurance framework for medicines made available through Pradhan Mantri Bhartiya Janaus…
Latest National Formulary of India News & Updates
New Delhi, April 11 (IANS) Health Ministry is reportedly considering banning prescriptions of paediatric cough syrups for children under two years and discouraging their use for those under five.Reports said that the move under a draft of the National Formulary of India (NFI) 2026, released by the Indian Pharmacopoeia Commission, marks a notable shift in prescribing norms after a series of contamination-linked deaths last year.There was, however, no official word from Health Ministry on the repo…
New Delhi, Dec 26 (IANS) Union Health Minister JP Nadda on Friday undertook a review of the progress of Indian Pharmacopoeia Commission to ensure the quality of medicines.Pharmacovigilance by IPC plays a major role in safeguarding patient health. The body regulates the quality, safety, and efficacy of the India-made medicines for both the domestic and global markets.Nadda stated that the efforts signal the country’s growing scientific self-reliance. The meeting was themed ‘advancing towards Viks…